Timm Baumeister
Forma Therapeutics (United States)(US)
Publications by Year
Research Areas
Biochemical and Molecular Research, Sirtuins and Resveratrol in Medicine, Autophagy in Disease and Therapy, PARP inhibition in cancer therapy, Cancer Genomics and Diagnostics
Most-Cited Works
- → Structure-Based Discovery of Novel Amide-Containing Nicotinamide Phosphoribosyltransferase (Nampt) Inhibitors(2013)80 cited
- → Structure-Based Identification of Ureas as Novel Nicotinamide Phosphoribosyltransferase (Nampt) Inhibitors(2013)68 cited
- → Identification of amides derived from 1H-pyrazolo[3,4-b]pyridine-5-carboxylic acid as potent inhibitors of human nicotinamide phosphoribosyltransferase (NAMPT)(2013)41 cited
- → Discovery of potent and efficacious urea-containing nicotinamide phosphoribosyltransferase (NAMPT) inhibitors with reduced CYP2C9 inhibition properties(2013)41 cited
- → Fragment-Based Identification of Amides Derived from trans-2-(Pyridin-3-yl)cyclopropanecarboxylic Acid as Potent Inhibitors of Human Nicotinamide Phosphoribosyltransferase (NAMPT)(2014)38 cited
- → Identification of 2,3-dihydro-1H-pyrrolo[3,4-c]pyridine-derived ureas as potent inhibitors of human nicotinamide phosphoribosyltransferase (NAMPT)(2013)32 cited
- → Identification of nicotinamide phosphoribosyltransferase (NAMPT) inhibitors with no evidence of CYP3A4 time-dependent inhibition and improved aqueous solubility(2014)28 cited
- → Fragment-based design of 3-aminopyridine-derived amides as potent inhibitors of human nicotinamide phosphoribosyltransferase (NAMPT)(2013)23 cited
- → Discovery of potent and efficacious cyanoguanidine-containing nicotinamide phosphoribosyltransferase (Nampt) inhibitors(2013)16 cited
- → Discovery of novel biaryl sulfonamide based Mcl-1 inhibitors(2019)9 cited